Lung sarcomatoid carcinoma (LSC) harbors targetable genomic alterations and high mutational burden as observed by comprehensive genomic profiling (CGP)

B. Halmos, G. M. Frampton, J. Suh, E. Braun, R. Mehra, S. Buck, J. A. Bufill, N. Peled, N. A. Karim, P. Fishkin, J. Knost, S. H.I. Ou, J. S. Ross, P. J. Stephens, V. A. Miller, S. M. Ali, A. B. Schrock

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)vi419
JournalAnnals of Oncology
Volume27
DOIs
StatePublished - Oct 1 2016

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Halmos, B., Frampton, G. M., Suh, J., Braun, E., Mehra, R., Buck, S., Bufill, J. A., Peled, N., Karim, N. A., Fishkin, P., Knost, J., Ou, S. H. I., Ross, J. S., Stephens, P. J., Miller, V. A., Ali, S. M., & Schrock, A. B. (2016). Lung sarcomatoid carcinoma (LSC) harbors targetable genomic alterations and high mutational burden as observed by comprehensive genomic profiling (CGP). Annals of Oncology, 27, vi419. https://doi.org/10.1093/annonc/mdw383.12